Tunicamycin partially delays release of newly synthesized hyaluronate from Swarm rat chondrosarcoma chondrocytes.
Tunicamycin (5-100 micrograms/ml) inhibits total [3H]hyaluronate synthesis in cultures of Swarm rat chondrosarcoma chondrocytes by approx. 15%. In agreement with previous results (Lohmander, L.S., Fellini, S.K., Kimura, J.H., Stevens, R.L. and Hascall, V.C. (1983) J. Biol. Chem. 258, 12280-12286) the relative decrease in [3H]hyaluronate radioactivity in the culture medium was greater than in the cell layer. Treated cultures show a concentration-related decrease in the proportion of medium 35S-labelled proteoglycans forming 'natural aggregates'. Pulse-chase experiments in cultures pretreated with tunicamycin (100 micrograms/ml, 13 h) showed that 30-40% of the total [3H]hyaluronate synthesized is released more slowly from these chondrocytes than from control culture chondrocytes. Release of some hyaluronate molecules may be delayed by 6 h or more. After a 24 h chase period almost all the [3H]hyaluronate is released from the cells. The proportion of 35S-labelled proteoglycans present as aggregates in the 24 h chase medium (57%) remained depressed compared to controls (81%), although the monomers could form aggregates if exogenous hyaluronate was added. Hyaluronate synthesized in the presence of tunicamycin has the same hydrodynamic size as control culture hyaluronate, as assessed by its sedimentation profile in CsSO4 gradients and its chromatographic profile on a dissociative Sephacryl S-1000 column.
D000818:Animals; D002356:Cartilage / Q000187:drug effects* / Q000378:metabolism; D002478:Cells, Cultured; D002813:Chondrosarcoma / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism; D006820:Hyaluronic Acid / Q000096:biosynthesis / Q000378:metabolism*; D011509:Proteoglycans / Q000378:metabolism; D051381:Rats; D014415:Tunicamycin / Q000494:pharmacology*
D011509:Proteoglycans; D014415:Tunicamycin; D006820:Hyaluronic Acid